Complement as a target in COVID-19?

There is an urgent need to develop effective therapies for COVID-19. Here, we urge immunologists and clinicians to consider the potential of targeting the complement system in these patients.

Detalles Bibliográficos
Autores principales: Risitano, Antonio M., Mastellos, Dimitrios C., Huber-Lang, Markus, Yancopoulou, Despina, Garlanda, Cecilia, Ciceri, Fabio, Lambris, John D.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2020
Materias:
Comment
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7187144/
https://www.ncbi.nlm.nih.gov/pubmed/32327719
http://dx.doi.org/10.1038/s41577-020-0320-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7187144/
https://www.ncbi.nlm.nih.gov/pubmed/32327719
http://dx.doi.org/10.1038/s41577-020-0320-7

Ejemplares similares